OBX (Obsidian Therapeutics) Interest Expense: $ Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OBX Obsidian Therapeutics Inc OBX
8 GF Score
Price $27.50
View Full Analysis

What is Obsidian Therapeutics Interest Expense?

Obsidian Therapeutics OBX -1.79% 8 Interest Expense is $ Mil as of Dec. 2025. GuruFocus rates OBX with a GF Score™ of 8/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Obsidian Therapeutics's interest expense for the six months ended in Dec. 2025 was $ 0.00 Mil. Obsidian Therapeutics does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2025.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Obsidian Therapeutics's Operating Income for the six months ended in Dec. 2025 was $ -105.67 Mil. Obsidian Therapeutics's Interest Expense for the six months ended in Dec. 2025 was $ 0.00 Mil. GuruFocus does not calculate Obsidian Therapeutics's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Obsidian Therapeutics  (NAS:OBX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Obsidian Therapeutics's Interest Expense for the six months ended in Dec. 2025 was $0.00 Mil. Its Operating Income for the six months ended in Dec. 2025 was $-105.67 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $1.22 Mil.

Obsidian Therapeutics's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

GuruFocus does not calculate Obsidian Therapeutics's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Obsidian Therapeutics Interest Expense Historical Data

* Premium members only.

The historical data trend for Obsidian Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Obsidian Therapeutics Interest Expense Chart

Obsidian Therapeutics Annual Data
Trend Dec24 Dec25
Interest Expense
0.00 0.00

Obsidian Therapeutics Semi-Annual Data
Dec24 Dec25
Interest Expense 0.00 0.00
OBX
8GF Score
Obsidian Therapeutics Inc OBX
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Obsidian Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $ Mil mean?
Obsidian Therapeutics (OBX) has a Interest Expense of $ Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Obsidian Therapeutics and its competitors.
Is Obsidian Therapeutics' Interest Expense too high?
Obsidian Therapeutics' current Interest Expense is $ Mil. Overall, Obsidian Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Obsidian Therapeutics' Interest Expense compare to ?
Obsidian Therapeutics' Interest Expense of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Obsidian Therapeutics and its competitors. Obsidian Therapeutics's current Interest Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Obsidian Therapeutics stock overvalued right now?
Obsidian Therapeutics (OBX) has a current Interest Expense of $ Mil. The current Interest Expense is $ Mil. Obsidian Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Obsidian Therapeutics (OBX), the current Interest Expense is $ Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Obsidian Therapeutics Business Description

Comparable Companies
Address 1030 Massachusetts Avenue, Suite 400, Cambridge, MA, USA, 02138
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.
8GF Score

Get the complete analysis for OBX

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.50
Price